Welcome to our dedicated page for Autozone SEC filings (Ticker: AZO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AutoZone, Inc. filings document formal disclosures for a NYSE-listed retailer and distributor of automotive replacement parts and accessories. Recent Form 8-K reports furnish quarterly earnings releases, same-store sales by domestic and international store base, margin items such as LIFO charges, operating results, and activity under the company's common stock repurchase program.
Governance filings include a definitive proxy statement and annual meeting vote results covering director elections, executive compensation, annual meeting proposals, and related board matters. Other current reports disclose leadership and board compensation changes, while the company's registered common stock and exchange listing are identified in its Exchange Act filings.
AutoZone Senior VP & CIO K. Michelle Borninkhof reported multiple transactions on June 20, 2025:
- Exercised 750 non-qualified stock options at $1,519.62 per share (granted under the 2011 Equity Incentive Award Plan)
- Sold 200 shares at $3,600.80 per share
- Sold additional 550 shares at $3,595.80 per share
Following these transactions, Borninkhof holds 406 shares directly and retains 1,350 unexercised stock options expiring May 10, 2031. The options were originally granted with a four-year vesting schedule from 2022 to 2025. The transactions resulted in a significant reduction of direct share ownership from 1,156 to 406 shares, suggesting a profit-taking move after option exercise.
AutoZone insider filed a Form 144 notice for the proposed sale of 750 shares of common stock with an aggregate market value of $2,697,850, indicating a per-share price of approximately $3,597. The sale is planned to be executed through Fidelity Brokerage Services on the NYSE, with an approximate sale date of June 20, 2025.
The securities were originally acquired through a stock option grant dated May 10, 2021, which was exercised on June 20, 2025 with a cash payment. The filing indicates there were 16,728,714 shares outstanding at the time of the notice.
Key points:
- Transaction represents approximately 0.004% of total outstanding shares
- No other securities were sold by the insider during the past 3 months
- Sale will be executed through NYSE via Fidelity Brokerage
- Securities were obtained through option exercise with cash payment